Activation and resolution of periodontal inflammation and its systemic impact

Periodontology 2000

Volumn 69, Issue 1, 2015, Pages 255-273

  Hasturk, Hatice ^a   Kantarci, Alpdogan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BLOODBORNE BACTERIUM; CARDIOVASCULAR DISEASE; COMPLICATION; HUMAN; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTITIS; RISK FACTOR;

ANIMALS; BLOOD-BORNE PATHOGENS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; PERIODONTITIS; RISK FACTORS;

EID: 84938588283     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/prd.12105     Document Type: Article

References (140)

1. Ahlqvist E, van Zuydam NR, Groop LC, McCarthy MI. The genetics of diabetic complications. Nat Rev Nephrol 2015: 11: 277-287.
2. Al-Zaubai N, Johnstone CN, Leong MM, Li J, Rizzacasa M, Stewart AG. Resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor. J Pharmacol Exp Ther 2014: 351: 172-180.
3. Allen EM, Matthews JB, O'Halloran DJ, Griffiths HR, Chapple IL. Oxidative and inflammatory status in Type 2 diabetes patients with periodontitis. J Clin Periodontol 2011: 38: 894-901.
4. Angst PD, Dutra DA, Moreira CH, Kantorski KZ. Periodontal status and its correlation with haematological parameters in patients with leukaemia. J Clin Periodontol 2012: 39: 1003-1010.
5. Armitage GC, Robertson PB. The biology, prevention, diagnosis and treatment of periodontal diseases: scientific advances in the United States. J Am Dent Assoc 2009: 140 (Suppl. 1): 36S-43S.
6. Back M, Powell WS, Dahlen SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7. Br J Pharmacol 2014: 171: 3551-3574.
7. Bagchi A, Herrup EA, Warren HS, Trigilio J, Shin HS, Valentine C, Hellman J. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol 2007: 178: 1164-1171.
8. Bahrani-Mougeot FK, Paster BJ, Coleman S, Ashar J, Knost S, Sautter RL, Lockhart PB. Identification of oral bacteria in blood cultures by conventional versus molecular methods. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008: 105: 720-724.
9. Bastos AS, Graves DT, Loureiro AP, Rossa Junior C, Abdalla DS, Faulin Tdo E, Olsen Camara N, Andriankaja OM, Orrico SR. Lipid peroxidation is associated with the severity of periodontal disease and local inflammatory markers in patients with type 2 diabetes. J Clin Endocrinol Metab 2012: 97: E1353-E1362.
10. Borgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, Roche HM, Godson C. Lipoxin A4 attenuates adipose inflammation. FASEB J 2012: 26: 4287-4294.
11. Bosshardt DD, Lang NP. The junctional epithelium: from health to disease. J Dent Res 2005: 84: 9-20.
12. Boylan MR, Khalili H, Huang ES, Michaud DS, Izard J, Joshipura KJ, Chan AT. A prospective study of periodontal disease and risk of gastric and duodenal ulcer in male health professionals. Clin Transl Gastroenterol 2014: 5: e49.
13. Bretz WA, Weyant RJ, Corby PM, Ren D, Weissfeld L, Kritchevsky SB, Harris T, Kurella M, Satterfield S, Visser M, Newman AB. Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population. J Am Geriatr Soc 2005: 53: 1532-1537.
14. Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 2014: 64: 57-80.
15. Chapple IL, Genco R, Working group 2 of the joint EFPAAPw. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013: 84: S106-S112.
16. Chapple IL, Socransky SS, Dibart S, Glenwright HD, Matthews JB. Chemiluminescent assay of alkaline phosphatase in human gingival crevicular fluid: investigations with an experimental gingivitis model and studies on the source of the enzyme within crevicular fluid. J Clin Periodontol 1996: 23: 587-594.
17. Chapple IL, Wilson NH. Manifesto for a paradigm shift: periodontal health for a better life. Br Dent J 2014: 216: 159-162.
18. Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. The components of the immune system. Immunobiology, 5th edn. New York: Garland Science, 2001: 1-34.
19. Chou HH, Yumoto H, Davey M, Takahashi Y, Miyamoto T, Gibson FC 3rd, Genco CA. Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect Immun 2005: 73: 5367-5378.
20. Cohen RA, Donaldson JA. The study of dental history. Int Dent J 1967: 17: 134-139.
21. Corbella S, Francetti L, Taschieri S, De Siena F, Fabbro MD. Effect of periodontal treatment on glycemic control of patients with diabetes: a systematic review and meta-analysis. J Diabetes Investig 2013: 4: 502-509.
22. Cotran RS, Kumar V, Collins T (eds). Robbins pathologic basis of disease. Los Angeles, CA: W.B. Saunders Co, 1999.
23. Crasta K, Daly CG, Mitchell D, Curtis B, Stewart D, Heitz-Mayfield LJ. Bacteraemia due to dental flossing. J Clin Periodontol 2009: 36: 323-332.
24. Das UN. Essential fatty acids as possible mediators of the actions of statins. Prostaglandins Leukot Essent Fatty Acids 2001: 65: 37-40.
25. Das UN. Is obesity an inflammatory condition? Nutrition 2001: 17: 953-966.
26. Demmer RT, Desvarieux M, Holtfreter B, Jacobs DR Jr, Wallaschofski H, Nauck M, Volzke H, Kocher T. Periodontal status and A1C change: longitudinal results from the study of health in Pomerania (SHIP). Diabetes Care 2010: 33: 1037-1043.
27. Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 1998: 66: 5337-5343.
28. Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Periodontol 2013: 84: S70-S84.
29. Ding Y, Kantarci A, Badwey JA, Hasturk H, Malabanan A, Van Dyke TE. Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol 2007: 179: 647-654.
30. Dowsett SA, Archila L, Foroud T, Koller D, Eckert GJ, Kowolik MJ. The effect of shared genetic and environmental factors on periodontal disease parameters in untreated adult siblings in Guatemala. J Periodontol 2002: 73: 1160-1168.
31. Engebretson S, Chertog R, Nichols A, Hey-Hadavi J, Celenti R, Grbic J. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. J Clin Periodontol 2007: 34: 18-24.
32. Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato MC, Hou W, Seaquist ER, Reddy MS, Lewis CE, Oates TW, Tripathy D, Katancik JA, Orlander PR, Paquette DW, Hanson NQ, Tsai MY. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial. JAMA 2013: 310: 2523-2532.
33. Genco RJ, Loe H. The role of systemic conditions and disorders in periodontal disease. Periodontol 2000 1993: 2: 98-116.
34. Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004: 3: 401-416.
35. Goncalves LS, Goncalves BM, Fontes TV. Periodontal disease in HIV-infected adults in the HAART era: clinical, immunological, and microbiological aspects. Arch Oral Biol 2013: 58: 1385-1396.
36. Gradmann C. A spirit of scientific rigour: Koch's postulates in twentieth-century medicine. Microbes Infect 2014: 16: 885-892.
37. Grande SR, Imbronito AV, Okuda OS, Pannuti CM, Nunes FD, Lima LA. Relationship between herpesviruses and periodontopathogens in patients with HIV and periodontitis. J Periodontol 2011: 82: 1442-1452.
38. Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci 2008: 13: 1227-1239.
39. Gronert K, Kantarci A, Levy BD, Clish CB, Odparlik S, Hasturk H, Badwey JA, Colgan SP, Van Dyke TE, Serhan CN. A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J Immunol 2004: 172: 1856-1861.
40. Haffajee AD, Socransky SS. Microbiology of periodontal diseases: introduction. Periodontol 2000 2005: 38: 9-12.
41. Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol 2014: 35: 3-11.
42. Hale GC. Focal infection and its relation to disease. Can Med Assoc J 1931: 24: 537-539.
43. Han YW, Redline RW, Li M, Yin L, Hill GB, McCormick TS. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun 2004: 72: 2272-2279.
44. Han YW, Wang X. Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J Dent Res 2013: 92: 485-491.
45. Harper DS, Robinson PJ. Correlation of histometric, microbial, and clinical indicators of periodontal disease status before and after root planing. J Clin Periodontol 1987: 14: 190-196.
46. Hasturk H, Abdallah R, Kantarci A, Nguyen D, Giordano N, Hamilton J, Van Dyke TE. Resolvin E1 attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis. Arterioscler Thromb Vasc Biol 2015: 35: 1123-1133.
47. Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 2007: 179: 7021-7029.
48. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van Dyke TE. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J 2006: 20: 401-403.
49. Hasturk H, Kantarci A, Van Dyke TE. Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol 2012: 3: 118.
50. Hasturk H, Kantarci A, Van Dyke TE. Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol 2012: 15: 160-176.
51. Hayashi C, Gudino CV, Gibson FC 3rd, Genco CA. Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol 2010: 25: 305-316.
52. Herrera BS, Hasturk H, Kantarci A, Freire MO, Nguyen O, Kansal S, Van Dyke TE. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. Infect Immun 2015: 83: 792-801.
53. Hillam C. James Blair (1747-1817), provincial dentist. Med Hist 1978: 22: 44-70.
54. Hirschfeld J, Kawai T. Oral inflammation and bacteremia: implications for chronic and acute systemic diseases involving major organs. Cardiovasc Hematol Disord Drug Targets 2015: 15: 70-84.
55. Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol 2010: 177: 2116-2123.
56. Holtfreter B, Empen K, Glaser S, Lorbeer R, Volzke H, Ewert R, Kocher T, Dorr M. Periodontitis is associated with endothelial dysfunction in a general population: a cross-sectional study. PLoS One 2013: 8: e84603.
57. Ide M, Linden GJ. Periodontitis, cardiovascular disease and pregnancy outcome-focal infection revisited? Br Dent J 2014: 217: 467-474.
58. Jagannathan M, Hasturk H, Liang Y, Shin H, Hetzel JT, Kantarci A, Rubin D, McDonnell ME, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol 2009: 183: 7461-7470.
59. Jagannathan M, McDonnell M, Liang Y, Hasturk H, Hetzel J, Rubin D, Kantarci A, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010: 53: 1461-1471.
60. Jain A, Batista EL Jr, Serhan C, Stahl GL, Van Dyke TE. Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 2003: 71: 6012-6018.
61. Jeffcoat MK, Reddy MS, Moreland LW, Koopman WJ. Effects of nonsteroidal antiinflammatory drugs on bone loss in chronic inflammatory disease. Ann N Y Acad Sci 1993: 696: 292-302.
62. Jeffcoat MK, Williams RC, Reddy MS, English R, Goldhaber P. Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism. J Periodontal Res 1988: 23: 381-385.
63. Kantarci A, Hasturk H, Van Dyke TE. Host-mediated resolution of inflammation in periodontal diseases. Periodontol 2000 2006: 40: 144-163.
64. Kantarci A, Oyaizu K, Van Dyke TE. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol 2003: 74: 66-75.
65. Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam BH, Malabanan A, Trackman PC, Badwey JA, Van Dyke TE. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol 2005: 78: 862-870.
66. Kinane DF, Lappin DF. Immune processes in periodontal disease: a review. Ann Periodontol 2002: 7: 62-71.
67. Kinane DF, Riggio MP, Walker KF, MacKenzie D, Shearer B. Bacteraemia following periodontal procedures. J Clin Periodontol 2005: 32: 708-713.
68. Kolattukudy PE, Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ Res 2012: 110: 174-189.
69. Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010: 53: 10-20.
70. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997: 14: 33-53.
71. Koromantzos PA, Madianos P. Nonsurgical periodontal treatment can improve HbA1c values in a Mexican-American population of patients with type 2 diabetes mellitus (DM2) and periodontal disease (PD). J Evid Based Dent Pract 2014: 14: 193-194.
72. Kramer JM, Gaffen SL. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007: 78: 1083-1093.
73. Kumar V, Abbas AK, Fausto N. Robbins and Cotran pathologic basis of disease, 7th edn. Philadelphia, PA: Elsevier Saunders, 2005.
74. Lalla E, Lamster IB, Feit M, Huang L, Schmidt AM. A murine model of accelerated periodontal disease in diabetes. J Periodontal Res 1998: 33: 387-399.
75. Lalla E, Lamster IB, Schmidt AM. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes. Ann Periodontol 1998: 3: 13-19.
76. Leigh NJ, Nelson JW, Mellas RE, Aguirre A, Baker OJ. Expression of resolvin D1 biosynthetic pathways in salivary epithelium. J Dent Res 2014: 93: 300-305.
77. Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002: 105: 861-867.
78. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000: 13: 547-558.
79. Li Y, Lu Z, Zhang X, Yu H, Kirkwood KL, Lopes-Virella MF, Huang Y. Metabolic syndrome exacerbates inflammation and bone loss in periodontitis. J Dent Res 2015: 94: 362-370.
80. Libby P, Hansson GK. Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res 2015: 116: 307-311.
81. Lindhe J, Meyle J, Group DoEWoP. Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008: 35: 282-285.
82. Lockhart PB, Brennan MT, Kent ML, Norton HJ, Weinrib DA. Impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia in children after intubation and dental procedures. Circulation 2004: 109: 2878-2884.
83. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation 2008: 117: 3118-3125.
84. Loe H. Periodontal diseases: a brief historical perspective. Periodontol 2000 1993: 2: 7-12.
85. Maekawa T, Tabeta K, Kajita-Okui K, Nakajima T, Yamazaki K. Increased expression of C-reactive protein gene in inflamed gingival tissues could be derived from endothelial cells stimulated with interleukin-6. Arch Oral Biol 2011: 56: 1312-1318.
86. Magnusson I, Lindhe J, Yoneyama T, Liljenberg B. Recolonization of a subgingival microbiota following scaling in deep pockets. J Clin Periodontol 1984: 11: 193-207.
87. Makiura N, Ojima M, Kou Y, Furuta N, Okahashi N, Shizukuishi S, Amano A. Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment. Oral Microbiol Immunol 2008: 23: 348-351.
88. Marcon R, Bento AF, Dutra RC, Bicca MA, Leite DF, Calixto JB. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. J Immunol 2013: 191: 4288-4298.
89. Marsh PD, Moter A, Devine DA. Dental plaque biofilms: communities, conflict and control. Periodontol 2000 2011: 55: 16-35.
90. Martin CR, Zaman MM, Gilkey C, Salguero MV, Hasturk H, Kantarci A, Van Dyke TE, Freedman SD. Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. PLoS One 2014: 9: e98773.
91. Miles B, Zakhary I, El-Awady A, Scisci E, Carrion J, O'Neill JC, Rawlings A, Stern JK, Susin C, Cutler CW. Secondary lymphoid organ homing phenotype of human myeloid dendritic cells disrupted by an intracellular oral pathogen. Infect Immun 2014: 82: 101-111.
92. Miller WD. The human mouth as a focus of infection. Lancet 1891: 138: 340-342.
93. Mizutani K, Park K, Mima A, Katagiri S, King GL. Obesity-associated gingival vascular inflammation and insulin resistance. J Dent Res 2014: 93: 596-601.
94. Mustafa M, Zarrough A, Bolstad AI, Lygre H, Mustafa K, Hasturk H, Serhan C, Kantarci A, Van Dyke TE. Resolvin D1 protects periodontal ligament. Am J Physiol Cell Physiol 2013: 305: C673-C679.
95. Nishihara R, Sugano N, Takano M, Shimada T, Tanaka H, Oka S, Ito K. The effect of Porphyromonas gingivalis infection on cytokine levels in type 2 diabetic mice. J Periodontal Res 2009: 44: 305-310.
96. Norling LV, Spite M, Yang R, Flower RJ, Perretti M, Serhan CN. Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. J Immunol 2011: 186: 5543-5547.
97. Offenbacher S, Williams RC, Jeffcoat MK, Howell TH, Odle BM, Smith MA, Hall CM, Johnson HG, Goldhaber P. Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss. J Periodontal Res 1992: 27: 207-213.
98. Paquette DW, Williams RC. Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000 2000: 24: 239-252.
99. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008: 35: 277-290.
100. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE. Bacterial diversity in human subgingival plaque. J Bacteriol 2001: 183: 3770-3783.
101. Payne JB, Golub LM, Thiele GM, Mikuls TR. The link between periodontitis and rheumatoid arthritis: a periodontist's perspective. Curr Oral Health Rep 2015: 2: 20-29.
102. Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E, Serhan CN. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 2002: 8: 1296-1302.
103. Pober JS, Min W, Bradley JR. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 2009: 4: 71-95.
104. Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 2000: 39: 4761-4768.
105. Preshaw PM, Foster N, Taylor JJ. Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontol 2000 2007: 45: 138-157.
106. Progulske-Fox A, Kozarov E, Dorn B, Dunn W Jr, Burks J, Wu Y. Porphyromonas gingivalis virulence factors and invasion of cells of the cardiovascular system. J Periodontal Res 1999: 34: 393-399.
107. Rao X, Zhong J, Sun Q. The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetes. Life Sci 2014: 116: 59-66.
108. Richardson M, De Reske M, Delaney K, Fletch A, Wilcox LH, Kinlough-Rathbone RL. Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1. Am J Pathol 1997: 151: 1009-1017.
109. Richardson M, Fletch A, Delaney K, DeReske M, Wilcox LH, Kinlough-Rathbone RL. Increased expression of vascular cell adhesion molecule-1 by the aortic endothelium of rabbits with Pasteurella multocida pneumonia. Lab Anim Sci 1997: 47: 27-35.
110. Rivers JP, Frankel TL. Essential fatty acid deficiency. Br Med Bull 1981: 37: 59-64.
111. Rodrigues PH, Reyes L, Chadda AS, Belanger M, Wallet SM, Akin D, Dunn W Jr, Progulske-Fox A. Porphyromonas gingivalis strain specific interactions with human coronary artery endothelial cells: a comparative study. PLoS One 2012: 7: e52606.
112. Russell CD, Schwarze J. The role of pro-resolution lipid mediators in infectious disease. Immunology 2014: 141: 166-173.
113. Sanz M, Kornman K, working group 3 of the joint EFPAAPw. Periodontitis and adverse pregnancy outcomes: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013: 84: S164-S169.
114. Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 1996: 45 (Suppl. 3): S77-S80.
115. Schmidt AM, Weidman E, Lalla E, Yan SD, Hori O, Cao R, Brett JG, Lamster IB. Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res 1996: 31: 508-515.
116. Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004: 39: 1125-1132.
117. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007: 21: 325-332.
118. Serhan CN, Chiang N. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entree for resoleomics. Rheum Dis Clin North Am 2004: 30: 69-95.
119. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005: 6: 1191-1197.
120. Shin H, Zhang Y, Jagannathan M, Hasturk H, Kantarci A, Liu H, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. B cells from periodontal disease patients express surface Toll-like receptor 4. J Leukoc Biol 2009: 85: 648-655.
121. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005: 35: 135-187.
122. Spite M, Claria J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 2014: 19: 21-36.
123. Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, Flower RJ, Perretti M, Serhan CN. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 2009: 461: 1287-1291.
124. Sugano N, Ikeda K, Oshikawa M, Sawamoto Y, Tanaka H, Ito K. Differential cytokine induction by two types of Porphyromonas gingivalis. Oral Microbiol Immunol 2004: 19: 121-123.
125. Thomas MV, Puleo DA. Infection, inflammation, and bone regeneration: a paradoxical relationship. J Dent Res 2011: 90: 1052-1061.
126. Tonetti MS, Van Dyke TE, working group 1 of the joint EFPAAPw. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013: 84: S24-S29.
127. Van Dyke TE, Hasturk H, Kantarci A, Freire MO, Nguyen D, Dalli J, Serhan CN. Proresolving nanomedicines activate bone regeneration in periodontitis. J Dent Res 2015: 94: 148-156.
128. Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003: 82: 82-90.
129. Van Winkelhoff AJ, Boutaga K. Transmission of periodontal bacteria and models of infection. J Clin Periodontol 2005: 32 (Suppl. 6): 16-27.
130. Vaudo G, Marchesi S, Siepi D, Brozzetti M, Lombardini R, Pirro M, Alaeddin A, Roscini AR, Lupattelli G, Mannarino E. Human endothelial impairment in sepsis. Atherosclerosis 2008: 197: 747-752.
131. Vita JA, Loscalzo J. Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation 2002: 106: 164-166.
132. Williams RC, Jeffcoat MK, Kaplan ML, Goldhaber P, Johnson HG, Wechter WJ. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science 1985: 227: 640-642.
133. Williams RC, Jeffcoat MK, Wechter WJ, Johnson HG, Kaplan ML, Goldhaber P. Non-steroidal anti-inflammatory drug treatment of periodontitis in beagles. J Periodontal Res 1984: 19: 633-637.
134. Williams RC, Leone CW, Jeffcoat MK, Scott ER, Goldhaber P. Tetracycline treatment of periodontal disease in the beagle dog. I. Clinical and radiographic course over 12 months-maximal effect on rate of alveolar bone loss. J Periodontal Res 1981: 16: 659-665.
135. Williams RC, Paquette DW, Offenbacher S, Adams DF, Armitage GC, Bray K, Caton J, Cochran DL, Drisko CH, Fiorellini JP, Giannobile WV, Grossi S, Guerrero DM, Johnson GK, Lamster IB, Magnusson I, Oringer RJ, Persson GR, Van Dyke TE, Wolff LF, Santucci EA, Rodda BE, Lessem J. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol 2001: 72: 1535-1544.
136. Wisner FP. Focal infection, a medico-dental problem. Cal West Med 1925: 23: 977-980.
137. Wood NH, Blignaut E, Lemmer J, Meyerov R, Feller L. Necrotizing periodontal diseases in a semirural district of South Africa. AIDS Res Treat 2011: 2011: 638584.
138. Wright HJ, Matthews JB, Chapple IL, Ling-Mountford N, Cooper PR. Periodontitis associates with a type 1 IFN signature in peripheral blood neutrophils. J Immunol 2008: 181: 5775-5784.
139. Yumoto H, Chou HH, Takahashi Y, Davey M, Gibson FC 3rd, Genco CA. Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion. Infect Immun 2005: 73: 8050-8059.
140. Zhu M, Belkina AC, DeFuria J, Carr JD, Van Dyke TE, Gyurko R, Nikolajczyk BS. B cells promote obesity-associated periodontitis and oral pathogen-associated inflammation. J Leukoc Biol 2014: 96: 349-357.